Cover Image: Volume 86 Issue 4

Key Points

• Mapping molecular diversity shows significant implications for understanding prostate cancer progression.
• Key evidence reveals distinct biomarkers identified through multiplex immunohistochemistry and RNA in situ hybridization methods.
• Assessment using advanced imaging techniques highlights unique molecular features across prostate cancer samples.
• Findings suggest tailored therapeutic strategies may be developed based on molecular profiles in prostate cancer.

Abstract